The gene expression profile of matrix metalloproteinases and their inhibitors in children with Henoch-Schönlein purpura

British Journal of Dermatology

Volumn 164, Issue 6, 2011, Pages 1348-1355

  Shin, J I ^a   Song, K S ^a   Kim, H ^a   Cho, N H ^a   Kim, J ^a   Kim, H S ^a   Lee, J S ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 26; MATRIX METALLOPROTEINASE 28; NEUTROPHIL COLLAGENASE; STEROID; STROMELYSIN; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG;

ANAPHYLACTOID PURPURA; ARTHRALGIA; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EDEMA; FEMALE; GENE EXPRESSION PROFILING; HUMAN; MALE; NEPHRITIS; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA PURIFICATION; SOFT TISSUE; STEROID THERAPY; TREATMENT DURATION;

ABDOMINAL PAIN; ACUTE DISEASE; ARTHRALGIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA, COMPLEMENTARY; EDEMA; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MATRIX METALLOPROTEINASES; NEPHRITIS; PURPURA, SCHOENLEIN-HENOCH; REAL-TIME POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 79957600358     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10295.x     Document Type: Article

References (31)

1. Davin JC, Weening JJ,. Henoch-Schönlein purpura nephritis: an update. Eur J Pediatr 2001; 160: 689-95.
2. Ronkainen J, Nuutinen M, Koskimies O,. The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study. Lancet 2002; 360: 666-70. (Pubitemid 35232334)
3. Besbas N, Saatci U, Ruacan S, et al. The role of cytokines in Henoch-Schönlein purpura. Scand J Rheumatol 1997; 26: 456-60.
4. Nagase H, Visse R, Murphy G,. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006; 69: 562-73. (Pubitemid 43139720)
5. Parks WC, Wilson CL, Lõpez-Boado YS,. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004; 4: 617-29. (Pubitemid 39025047)
6. Borden P, Heller RA,. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr 1997; 7: 159-78. (Pubitemid 27148904)
7. Kobayashi T, Sakuraoka K, Iwamoto M, et al. A case of anaphylactoid purpura with multiple blister formation: possible pathophysiological role of gelatinase (MMP-9). Dermatology 1998; 197: 62-4. (Pubitemid 28327842)
8. Urushihara M, Kagami S, Kuhara T, et al. Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis. Nephrol Dial Transplant 2002; 17: 1189-96. (Pubitemid 34812062)
9. Zou CC, Zhao ZY, Tang LF, et al. Plasma levels of matrix metalloproteinase-9 in Henoch-Schönlein purpura. Scand J Rheumatol 2006; 35: 52-5. (Pubitemid 43247256)
10. Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990; 33: 1114-21. (Pubitemid 20273296)
11. Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006; 65: 936-41.
12. Kevorkian L, Young DA, Darrah C, et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 2004; 50: 131-41. (Pubitemid 38084297)
13. Senzaki H, Masutani S, Kobayashi J, et al. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation 2001; 104: 860-3. (Pubitemid 32778033)
14. Sanders JS, Huitema MG, Hanemaaijer R, et al. Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis. Am J Physiol Renal Physiol 2007; 293: F1927-34. (Pubitemid 350179617)
15. Segarra M, García-Martínez A, Sánchez M, et al. Gelatinase expression and proteolytic activity in giant-cell arteritis. Ann Rheum Dis 2007; 66: 1429-35. (Pubitemid 350032648)
16. Matsuyama A, Sakai N, Ishigami M, et al. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation 2003; 108: 1469-73. (Pubitemid 37176453)
17. Rijken F, Kiekens RC, Bruijnzeel PL,. Skin-infiltrating neutrophils following exposure to solar-simulated radiation could play an important role in photoageing of human skin. Br J Dermatol 2005; 152: 321-8. (Pubitemid 40343605)
18. Niimi Y, Pawankar R, Kawana S,. Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of ·ous pemphigoid. Int Arch Allergy Immunol 2006; 139: 104-13. (Pubitemid 43177321)
19. Hattori Y, Nerusu KC, Bhagavathula N, et al. Vascular expression of matrix metalloproteinase-13 (collagenase-3) in basal cell carcinoma. Exp Mol Pathol 2003; 74: 230-7. (Pubitemid 36629219)
20. Järvinen TM, Kanninen P, Jeskanen L, et al. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus. Br J Dermatol 2007; 157: 970-80. (Pubitemid 47583514)
21. Seandel M, Noack-Kunnmann K, Zhu D, et al. Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. Blood 2001; 97: 2323-32. (Pubitemid 32291478)
22. Topaloglu R, Sungur A, Baskin E, et al. Vascular endothelial growth factor in Henoch-Schönlein purpura. J Rheumatol 2001; 28: 2269-73. (Pubitemid 32947874)
23. Tchetverikov I, Ronday HK, van El B, et al. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis 2004; 63: 881-3. (Pubitemid 38850466)
24. Rajasekhar L, Liou LB, Chan CY, et al. Matrix metalloproteinase-8 in sera and from polymorphonuclear leucocytes in rheumatoid arthritis: in vitro characterization and correlation with disease activity. Clin Exp Rheumatol 2004; 22: 597-602. (Pubitemid 39302937)
25. Akiyama K, Shikata K, Sugimoto H, et al. Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis. Res Commun Mol Pathol Pharmacol 1997; 95: 115-28. (Pubitemid 27147557)
26. Counahan R, Winterborn MH, White RH, et al. Prognosis of Henoch-Schönlein nephritis in children. Br Med J 1977; 2: 11-14.
27. Camp TM, Smiley LM, Hayden MR, Tyagi SC,. Mechanism of matrix accumulation and glomerulosclerosis in spontaneously hypertensive rats. J Hypertens 2003; 21: 1719-27. (Pubitemid 37076356)
28. Ahokas K, Lohi J, Illman SA, et al. Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is up-regulated by transforming growth factor-beta1 in keratinocytes. Lab Invest 2003; 83: 1887-99. (Pubitemid 38018552)
29. Namgoong MK, Lim BK, Kim JS,. Eosinophil cationic protein in Henoch-Schönlein purpura and in IgA nephropathy. Pediatr Nephrol 1997; 11: 703-6. (Pubitemid 27520533)
30. Yilmaz D, Kavakli K, Ozkayin N,. The elevated markers of hypercoagulability in children with Henoch-Schönlein purpura. Pediatr Hematol Oncol 2005; 22: 41-8. (Pubitemid 40054020)
31. Hoshino M, Takahashi M, Takai Y, Sim J,. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 1999; 104: 356-63. (Pubitemid 29420433)